close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lakewood-Amedex Biotherapeutics Inc. - Common Stock (NQ:LABT)

0.9696 -0.1804 (-15.69%)
Streaming Delayed Price Updated: 12:59 PM EDT, Sep 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 988,447
Open 1.090
Bid (Size) 0.9600 (900)
Ask (Size) 0.9700 (1,400)
Prev. Close 1.150
Today's Range 0.9227 - 1.090
52wk Range 1.100 - 98.20
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Lakewood-Amedex Biotherapeutics Announces Positive Data Against Recent Clinical Isolates from Infected Diabetic Foot Ulcers
Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) announced positive Minimum Inhibitory Concentration (MIC) data from recent clinical isolates for its lead clinical candidate, Nu-3. 
Via B2i Digital
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill

Performance

YTD
-98.9%
-98.9%
1 Month
-61.2%
-61.2%
3 Month
-72.1%
-72.1%
6 Month
-98.9%
-98.9%
1 Year
-98.9%
-98.9%

More News

Read More
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Lakewood-Amedex Biotherapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of Nu-3 for Infected Diabetic Foot Ulcers
Via B2i Digital
News headline image
Lakewood-Amedex Biotherapeutics CEO Issues Letter to Shareholders Highlighting Transformational Progress and Outlook for Nu-3
Via B2i Digital
Topics Intellectual Property
News headline image
Lakewood-Amedex announces IRB approval and clinical site readiness for the Phase 2a trial of Nu-3
Via B2i Digital
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Lakewood-Amedex Biotherapeutics Becomes a B2i Digital Featured Company
Via NewMediaWire
Topics Derivatives
News headline image
Tech Stocks LABT, ANY, INLF, GMGMF, ZCMD Under $2 Watch Now
Via AB Newswire
Topics Artificial Intelligence
Top movers analysis one hour before the close of the markets on 2026-07-22: top gainers and losers in today's session. ↗
Via Chartmill
Curious about the most active stocks on Wednesday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
Top movers analysis in the middle of the day on 2026-07-22: top gainers and losers in today's session. ↗
Via Chartmill
Gapping stocks in Wednesday's session ↗
Via Chartmill
News headline image
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
From Virtual Investor Conferences
Via GlobeNewswire

Frequently Asked Questions

Is Lakewood-Amedex Biotherapeutics Inc. - Common Stock publicly traded?
Yes, Lakewood-Amedex Biotherapeutics Inc. - Common Stock is publicly traded.
What exchange does Lakewood-Amedex Biotherapeutics Inc. - Common Stock trade on?
Lakewood-Amedex Biotherapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lakewood-Amedex Biotherapeutics Inc. - Common Stock?
The ticker symbol for Lakewood-Amedex Biotherapeutics Inc. - Common Stock is LABT on the Nasdaq Stock Market
What is the current price of Lakewood-Amedex Biotherapeutics Inc. - Common Stock?
The current price of Lakewood-Amedex Biotherapeutics Inc. - Common Stock is 0.9696
When was Lakewood-Amedex Biotherapeutics Inc. - Common Stock last traded?
The last trade of Lakewood-Amedex Biotherapeutics Inc. - Common Stock was at 09/29/26 12:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.